Lehnhardt Marcus, Bohm Jens, Hirsch Tobias, Behr Björn, Daigeler Adrien, Harati Kamran
Klinik für Plastische Chirurgie und Schwerbrandverletzte, Handchirurgiezentrum, Operatives Referenzzentrum für Gliedmaßentumore, BG Universitätskliniken Bergmannsheil, Bochum.
Handchir Mikrochir Plast Chir. 2017 Apr;49(2):103-110. doi: 10.1055/s-0043-106583. Epub 2017 May 24.
Radiation-induced angiosarcomas of the breast are rare secondary malignancies that occur after adjuvant radiation of breast cancer. They grow in a multifocal manner and frequently develop local recurrences. Therefore, they often pose a surgical challenge. Due to their rarity it is still unclear whether a radical surgical approach leads to a beneficial outcome. The aim of this study was to determine the prognostic significance of surgical margins. We retrospectively assessed the outcome of 18 patients who underwent surgical treatment at our institution. The median follow-up was 4.4 years. Univariate analyses were performed to determine the prognostic significance of the assessed factors on local recurrence-free survival (LRFS) and overall survival (OS). The median patient age was 66.3 years. The median latency between radiation and angiosarcoma occurrence was 6.9 years. The estimated 5-year rates for LRFS and OS were 25.0% (95% confidence interval [CI]: 7.8-47.2) and 53.8% (95% CI: 26.8-74.8). R0 resection of the primary lesion was associated with a significant improvement in LRFS (p=0.017) and OS (p=0.013). Moreover, R0 resection of the last local recurrence was also associated with a more favourable OS (p=0.040). Due to their aggressive growth pattern and pronounced tendency to local recurrence, a radical surgical approach should be sought in the treatment of radiation-induced angiosarcomas. Wherever feasible, surgical treatment should aim at R0 margins in order to improve local control and OS.
放射性诱发的乳腺血管肉瘤是乳腺癌辅助放疗后发生的罕见继发性恶性肿瘤。它们呈多灶性生长,且经常出现局部复发。因此,它们常常给手术带来挑战。由于其罕见性,目前仍不清楚根治性手术方法是否能带来有益的结果。本研究的目的是确定手术切缘的预后意义。我们回顾性评估了在我们机构接受手术治疗的18例患者的结果。中位随访时间为4.4年。进行单因素分析以确定评估因素对无局部复发生存期(LRFS)和总生存期(OS)的预后意义。患者中位年龄为66.3岁。放疗与血管肉瘤发生之间的中位潜伏期为6.9年。LRFS和OS的估计5年率分别为25.0%(95%置信区间[CI]:7.8 - 47.2)和53.8%(95%CI:26.8 - 74.8)。原发灶的R0切除与LRFS(p = 0.017)和OS(p = 0.013)的显著改善相关。此外,最后一次局部复发的R0切除也与更有利的OS相关(p = 0.040)。由于其侵袭性生长模式和明显的局部复发倾向,在放射性诱发的血管肉瘤治疗中应寻求根治性手术方法。只要可行,手术治疗应旨在获得R0切缘,以改善局部控制和OS。